According to Vanda Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 58,527,775. At the end of 2025 the company had 58,527,775 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 58.52 M | 0.38% |
2024 | 58.3 M | 1.35% |
2023 | 57.53 M | 1.55% |
2022 | 56.65 M | 1.55% |
2021 | 55.78 M | 2.05% |
2020 | 54.66 M | 2.39% |
2019 | 53.38 M | 1.78% |
2018 | 52.45 M | 16.75% |
2017 | 44.93 M | 2.19% |
2016 | 43.96 M | 2.69% |
2015 | 42.81 M | 13.8% |
2014 | 37.62 M | 13.04% |
2013 | 33.28 M | 17.89% |
2012 | 28.23 M | 0.45% |
2011 | 28.1 M | 0.37% |
2010 | 28 M | 2.97% |
2009 | 27.19 M | 2.05% |
2008 | 26.65 M | 0.14% |
2007 | 26.61 M | 21.68% |
2006 | 21.87 M | -95.35% |
2005 | 0.46 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 1,968,000,000 | 3,262.51% | ๐จ๐ญ Switzerland |
![]() Eli Lilly LLY | 897,989,151 | 1,434.30% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | 2,405,625,000 | 4,010.23% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 2,031,000,000 | 3,370.15% | ๐บ๐ธ USA |
![]() Pfizer PFE | 5,675,000,000 | 9,596.25% | ๐บ๐ธ USA |
![]() Titan Pharmaceuticals
TTNP | 914,000 | -98.44% | ๐บ๐ธ USA |
![]() Merck MRK | 2,516,394,128 | 4,199.49% | ๐บ๐ธ USA |